N/A
N=360
Apneic Oxygenation During Airway Management in Pediatric Patients
Hypoxia
Bottom Line
View on ClinicalTrials.gov: NCT02437864 ↗Enrolled (actual)
360
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcome: Primary: Time to First Event: Pulse Oximetry at 95%, or Successful Intubation — 106; 169 seconds
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Supplemental oxygen via nasal cannula (Device)
- Age
- Pediatric · 0+ yrs
- Sex
- All
- Sponsor
- University of New Mexico
- Primary completion
- Mar 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time to First Event: Pulse Oximetry at 95%, or Successful Intubation |
106; 169 | — |
| SECONDARY Number of Patients Whose Pulse Oximetry Falls Below 95% During Airway Placement |
85; 14 | — |
| SECONDARY Number of Patients Requiring Intervention by Attending or Temporary Mask Ventilation During Airway Placement |
52; 22 | — |
| SECONDARY Number of Patients Whose Pulse Oximetry Falls Below 90% During Airway Placement |
61; 7 | — |
| SECONDARY Patients' Lowest Pulse Oximetry Value Observed During Airway Placement |
97; 99 | — |
Summary
Airway placement after anesthetic induction in pediatric patients is routinely performed at our institution without apneic oxygenation. When intubation is attempted by an inexperienced (learner) provider, the attending physician intervenes if necessary before the patient experiences excessive loss of oxygenation. The investigators plan to institute routine supplemental oxygenation via nasal cannula during this placement. This study will examine the effect of adding apneic oxygenation via nasal cannula on oxygen saturation.
Eligibility Criteria
Inclusion Criteria
- Pediatric patients presenting for surgery at University of New Mexico Children's Hospital
- Age range: adjusted gestational age 40 weeks, to 8 years
Exclusion Criteria
- Patients whose airways would be maintained with mask ventilation only
- American Society of Anesthesiologists classes 4-6
Data sourced from ClinicalTrials.gov (NCT02437864). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.